Diabetes Glucose Test Strip Recall Issued Due to False Low Readings
Abbott Laboratories has issued a recall for about 359 glucose test strips sold under a variety of brand names, such as Precision Xceed Pro, Precision Xtra, MediSense Optium, Optium, Optium EZ and ReliOn Ultima. The blood-sugar test strips may provide a false low reading, posing a potential health risk for diabetics.
The diabetes glucose test strip recall was announced by the FDA and Abbott on Wednesday, warning diabetics who use the devices to test their blood sugar levels, that the test strips may provide false low readings.
Test strips affected by the recall were manufactured between January 2010 and May 2010, and were used with the following blood glucose monitoring systems:
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
- Precision Xtra
- Precision Xceed Pro
- MediSense Optium
- Optium EZ
- ReliOn Ultima
Problems with the blood glucose test strips involve a defect that limits the amount of blood that is absorbed by each strip, which may lead to false results. According to the FDA, the risk of a false low reading is increased if the blood sugar test strips are exposed to warm weather or stored for long periods of time.
Diabetes patients rely on the readings from the test strips to monitor their blood sugar levels. If a false low reading from the test strip is given, it may cause consumers to unnecessarily raise their blood glucose or to fail to treat elevated blood glucose.
Abbott has offered to replace any of the recalled glucose test strips. To determine whether a test strip is affected by the recall, consumers can contact Abbott Diabetes Care at 1-800-448-5234 or visit www.precisionoptiuminfo.com to look up test strip lot numbers.
Individuals who are impacted by the glucose test strip recall have been advised to use an alternate method to measure blood sugar levels or to purchase at least two weeks worth of new test strips while they wait for free replacements to be provided by Abbott.
The FDA has also recommended that diabetes patients monitor the amount of time it takes to for their blood-glucose meter to start the “countdown” after blood is applied to the test strip. If the meter takes longer than five (5) seconds to start the countdown, the test strip is likely defective and the results should not be used. Also, if the reading from a strip is lower than would be expected or does not match the way a diabetes patient feels, the FDA has recommended that they contact their health care provider.
michaelAugust 7, 2011 at 4:11 pm
i used the relion strips and insulin for years, saw a report on local tv and havent seen an update since, i investigated the story and found that indeed i had packages of recalled strips, no contact from local walmart,, i went to walmart pharmicy and asked them about it they insted of trying to help me they just wanted to know how i knew of recall, ispoke with pham manager and was told there was n[Show More]i used the relion strips and insulin for years, saw a report on local tv and havent seen an update since, i investigated the story and found that indeed i had packages of recalled strips, no contact from local walmart,, i went to walmart pharmicy and asked them about it they insted of trying to help me they just wanted to know how i knew of recall, ispoke with pham manager and was told there was noything they could do for me, since i had several boxes of recalled test strips i got upset and was asked not to return to their pharmacy
cheryJanuary 11, 2011 at 12:22 am
I'm wondering why I was not told about these test strips. I use reli brand ,my name is in their computer. The way I found out was I went to get more and there were none on the shelf,even then no one knew why. I found out the next day when I went back. How ae they going to re-pay for the faulty ones?
"*" indicates required fields
More Top Stories
A Camp Lejeune non-Hodgkin's lymphoma lawsuit blames the death of a woman on her exposure to contaminated water from the military base.
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.